Tab Bonny

451 total citations
6 papers, 358 citations indexed

About

Tab Bonny is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Tab Bonny has authored 6 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Virology and 2 papers in Oncology. Recurrent topics in Tab Bonny's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Tab Bonny is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Tab Bonny collaborates with scholars based in United States, United Kingdom and Italy. Tab Bonny's co-authors include Nathan Clumeck, Judith Millard, W. Garrett Nichols, Kimberly K. Adkison, H. M. Steel, Lloyd Curtis, Kabamba Kabeya, Eugénio Teófilo, Jaime E. Hernández and Trevor R. Scott and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Annals of Oncology.

In The Last Decade

Tab Bonny

6 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tab Bonny United States	6	251	227	60	49	46	6	358
I Jiménez‐Nácher Spain	7	247 1.0×	149 0.7×	122 2.0×	48 1.0×	47 1.0×	12	371
Lloyd Curtis United States	8	358 1.4×	285 1.3×	79 1.3×	206 4.2×	35 0.8×	12	498
Marchina van der Ende Netherlands	8	286 1.1×	197 0.9×	73 1.2×	53 1.1×	39 0.8×	15	408
Gema González‐Pardo Spain	7	348 1.4×	169 0.7×	128 2.1×	112 2.3×	37 0.8×	9	454
Corklin Steinhart United States	10	391 1.6×	275 1.2×	141 2.4×	169 3.4×	16 0.3×	21	566
Madeleine Willkom United States	7	168 0.7×	116 0.5×	75 1.3×	45 0.9×	21 0.5×	8	409
Helen Steel United Kingdom	10	305 1.2×	208 0.9×	157 2.6×	74 1.5×	16 0.3×	12	626
Debra Ogata-Arakaki United States	10	214 0.9×	91 0.4×	240 4.0×	85 1.7×	28 0.6×	13	437
Kenneth E. Sherman United States	7	92 0.4×	42 0.2×	110 1.8×	19 0.4×	52 1.1×	9	331
Cassidy Henegar United States	10	162 0.6×	55 0.2×	63 1.1×	56 1.1×	32 0.7×	28	269

Countries citing papers authored by Tab Bonny

Since Specialization

Citations

This map shows the geographic impact of Tab Bonny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tab Bonny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tab Bonny more than expected).

Fields of papers citing papers by Tab Bonny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tab Bonny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tab Bonny. The network helps show where Tab Bonny may publish in the future.

Co-authorship network of co-authors of Tab Bonny

This figure shows the co-authorship network connecting the top 25 collaborators of Tab Bonny. A scholar is included among the top collaborators of Tab Bonny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tab Bonny. Tab Bonny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Yéni, P., Anthony LaMarca, Daniel Berger, et al.. (2009). Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)^*. HIV Medicine. 10(2). 116–124. 10 indexed citations

2.

Currier, Judith S., Adriano Lazzarin, Louis Sloan, et al.. (2008). Antiviral Activity and Safety of Aplaviroc with Lamivudine/Zidovudine in HIV-Infected, Therapy-Naive Patients: The ASCENT (CCR102881) Study. Antiviral Therapy. 13(2). 297–306. 21 indexed citations

3.

Nichols, W. Garrett, H. M. Steel, Tab Bonny, et al.. (2007). Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140). Antimicrobial Agents and Chemotherapy. 52(3). 858–865. 117 indexed citations

4.

DeJesus, Edwin, Eugénio Teófilo, Jan Gerstoft, et al.. (2004). Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults. Clinical Infectious Diseases. 39(7). 1038–1046. 175 indexed citations

5.

Benson, Al B., Edith P. Mitchell, Neil Abramson, et al.. (2002). Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma. Annals of Oncology. 13(4). 576–581. 12 indexed citations

6.

Schilsky, Richard L., Ronald M. Bukowski, Howard A. Burris, et al.. (2000). A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer. Annals of Oncology. 11(4). 415–420. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact